Latest Biotechnology, Pharmaceutical and Healthcare News from SmartBrief

00:46 EST 22nd November 2017 | BioPortfolio

Here are the most relevant search results for "SmartBrief" found in our extensive news archives from over 250 global news sources.

More Information about SmartBrief on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SmartBrief for you to read. Along with our medical data and news we also list SmartBrief Clinical Trials, which are updated daily. BioPortfolio also has a large database of SmartBrief Companies for you to search.

Showing News Articles 1–25 of 3,500+ from SmartBrief

Monday 20th November 2017

Medtech industry unsure if India will address stent price concerns

AdvaMed expressed uncertainty about whether the Indian government will address the medical device industry's concerns on sten -More- 

Whitaker talks about medical device tax, 2018 priorities

AdvaMed President and CEO Scott Whitaker said he was optimistic that the medical device tax would not go into effect on Jan.  -More- 

FDA OKs AAT deficiency test from Grifols

The FDA granted Grifols approval for its blood-based alpha-1 antitrypsin deficiency test for use with DNA extracted from a dr -More- 

Artificial pancreas systems to be covered by Anthem

Anthem has granted a positive coverage policy decision for artificial pancreas systems, including Medtronic's MiniMed system, -More- 

First-in-human use of microsensor implant recorded by Implandata

The first-in-human validation of Implandata Ophthalmic Products' next-generation Eyemate microsensor implant was performed at -More- 

Calif. lab business analytics company to be acquired by Roche

Roche Holding agreed to pay an undisclosed amount for Viewics, a Sunnyvale, Calif.-based laboratory business analytics firm t -More- 

Neovasc gets $65.3M boost

Neovasc raised about $27.8 million in a private placement of senior secured convertible notes and Series E warrants and $37.5 -More- 

GOP tax bill would benefit medtech companies

A Republican tax bill that recently cleared the full House and the Senate Finance Committee would benefit multinational medic -More- 

I seek opportunity -- not security.

Dean Alfange, politician

Be the Buzz of BIO

Nominate your company to be the Buzz of BIO of the BIO CEO & Investor Conference in New York City on Feb. 12-13!  -More- 

Scientists propose way to produce biofuel from food waste

Scientists from Russia proposed using hydrothermal liquefaction to convert food waste into biofuel.  -More- 

EU reauthorizes glyphosate-resistant biotech sugar beet

Monsanto and KWS' glyphosate-resistant biotech sugar beet H7-1 was approved for reauthorization by European Food Safety Autho -More- 

ScPharmaceuticals raises $89.6M in IPO

An initial public offering brought in $89.6 million for scPharmaceuticals.  -More- 

Gazyva gains expanded indication

Roche's Gazyva was cleared by the FDA as a first-line treatment for patients with follicular lymphoma. -More- 

EU recommends Takeda's Adcetris for cutaneous T-cell lymphoma

Takeda received an endorsement from the Committee for Medicinal Products for Human Use to expand the use of Adcetris, or bren -More- 

FDA extends review of Lipocine's Tlando

The FDA changed the action date to May 8, 2018, for Lipocine's Tlando testosterone undecanoate to allow more time for the ana -More- 

Pfizer's Sutent approved by FDA for kidney cancer

Pfizer's Sutent, or sunitinib malate, was approved by the FDA as an adjuvant treatment for renal cell carcinoma in adult pati -More- 

Roche's hemophilia A drug gets FDA nod

Roche Holding was granted approval by the FDA for its Hemlibra, or emicizumab-kxwh, as a treatment for adult and pediatric pa -More- 

Friday 17th November 2017

A man may truly live in his dreams, his noblest dreams, but only, only if he is worthy of those dreams.

Harlan Ellison, writer

Brazil to adopt corn, cane-derived biofuel concept

Brazilian ethanol producers have been assessing the adoption of a concept that uses corn and cane in the production of biofue -More- 

Biotech mosquitoes to be tested in India

Scientists at the University of California's San Diego and Irvine campuses will use a $70 million grant from India's Tata Tru -More- 


Win a company presentation and registration at the BIO CEO and Investor Conference in NYC on Feb. 12-13! Enter by Nov.  -More- 

Merck, Cue Biopharma to collaborate on autoimmune disease studies

Using Cue Biopharma's Cue Biologics platform, the company will work with Merck to develop treatments for autoimmune diseases. -More- 

Bluebird bio announces first patient in trial of beta-thalassemia candidate

Bluebird bio's Phase III trial to assess its lead candidate, LentiGlobin, in transfusion-dependent beta-thalassemia patients  -More- 

Xarelto reduces amputation risk from PAD, deaths from CAD

Johnson & Johnson's blood thinner Xarelto, or rivaroxaban, taken with aspirin, cut the rate of major amputations in patients  -More- 

Quick Search

News Quicklinks